KEYTRUDA (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the KEYTRUDA drug offered from Merck Sharp & Dohme Corp.. This Programmed Death Receptor-1 Blocking Antibody [EPC],Programmed Death Receptor-1-directed Antibody Interactions [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
NON-PROPRIETARY NAME: | pembrolizumab |
SUBSTANCE NAME: | PEMBROLIZUMAB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Programmed Death Receptor-1 Blocking Antibody [EPC],Programmed Death Receptor-1-directed Antibody Interactions [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2014-09-04 |
END MARKETING DATE: | 0000-00-00 |
KEYTRUDA HUMAN PRESCRIPTION DRUG Details:
Item Description | KEYTRUDA from Merck Sharp & Dohme Corp. |
LABELER NAME: | Merck Sharp & Dohme Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/2mL) |
START MARKETING DATE: | 2014-09-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0006-3029_8435cc61-92b4-4718-ab09-e42585e92d19 |
PRODUCT NDC: | 0006-3029 |
APPLICATION NUMBER: | BLA125514 |
Other PEMBROLIZUMAB Pharmaceutical Manufacturers / Labelers: